Market Closed -
Nasdaq
16:30:01 2024-05-03 EDT
|
5-day change
|
1st Jan Change
|
1.57
USD
|
-5.99%
|
|
+18.94%
|
+177.88%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,797
|
3,050
|
2,493
|
424.8
|
107.8
|
288.3
|
-
|
-
|
Enterprise Value (EV)
1 |
3,951
|
1,988
|
1,759
|
-80.2
|
72.51
|
173.5
|
6.871
|
288.3
|
P/E ratio
|
-8.57
x
|
-6.83
x
|
-4.72
x
|
-1.15
x
|
-0.39
x
|
-1.85
x
|
-2.35
x
|
-2.39
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
33.1
x
|
19.9
x
|
24.5
x
|
4.61
x
|
1.2
x
|
3.97
x
|
4.22
x
|
4.54
x
|
EV / Revenue
|
34.5
x
|
13
x
|
17.3
x
|
-0.87
x
|
0.8
x
|
2.39
x
|
0.1
x
|
4.54
x
|
EV / EBITDA
|
-9.25
x
|
-4.84
x
|
-4.07
x
|
0.22
x
|
-0.28
x
|
-1.42
x
|
-0.05
x
|
-1.8
x
|
EV / FCF
|
-11.1
x
|
-6.2
x
|
-4.11
x
|
0.26
x
|
-0.37
x
|
-1.18
x
|
-0.04
x
|
-1.64
x
|
FCF Yield
|
-8.99%
|
-16.1%
|
-24.3%
|
386%
|
-267%
|
-84.7%
|
-2,663%
|
-61%
|
Price to Book
|
2.71
x
|
2.84
x
|
3.69
x
|
1.16
x
|
0.83
x
|
9.01
x
|
3.21
x
|
-
|
Nbr of stocks (in thousands)
|
175,922
|
179,399
|
184,557
|
187,954
|
190,771
|
183,624
|
-
|
-
|
Reference price
2 |
21.58
|
17.00
|
13.51
|
2.260
|
0.5650
|
1.570
|
1.570
|
1.570
|
Announcement Date
|
20-02-27
|
21-02-25
|
22-02-28
|
23-02-28
|
24-03-04
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
114.6
|
152.9
|
101.9
|
92.06
|
90.12
|
72.54
|
68.35
|
63.57
|
EBITDA
1 |
-426.9
|
-410.9
|
-432.3
|
-363.1
|
-255.9
|
-122.2
|
-130.6
|
-160.3
|
EBIT
1 |
-440
|
-425.1
|
-446.4
|
-376.2
|
-263.7
|
-161.4
|
-157.5
|
-174.6
|
Operating Margin
|
-383.92%
|
-278%
|
-438.05%
|
-408.63%
|
-292.59%
|
-222.45%
|
-230.5%
|
-274.6%
|
Earnings before Tax (EBT)
1 |
-440.1
|
-443.9
|
-523.3
|
-365
|
-276.3
|
-167.7
|
-167.3
|
-180.6
|
Net income
1 |
-440.7
|
-444.4
|
-523.8
|
-368.2
|
-276.1
|
-167.9
|
-167.5
|
-180.8
|
Net margin
|
-384.47%
|
-290.65%
|
-514.03%
|
-399.98%
|
-306.31%
|
-231.43%
|
-245.01%
|
-284.44%
|
EPS
2 |
-2.520
|
-2.490
|
-2.860
|
-1.970
|
-1.450
|
-0.8487
|
-0.6694
|
-0.6575
|
Free Cash Flow
1 |
-355
|
-320.5
|
-427.6
|
-309.7
|
-193.5
|
-147
|
-183
|
-176
|
FCF margin
|
-309.7%
|
-209.62%
|
-419.65%
|
-336.41%
|
-214.67%
|
-202.65%
|
-267.75%
|
-276.87%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-02-27
|
21-02-25
|
22-02-28
|
23-02-28
|
24-03-04
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
24.92
|
25.01
|
24.82
|
21.58
|
23.62
|
22.02
|
21.59
|
20.5
|
24.14
|
23.88
|
15.34
|
15.34
|
15.34
|
15.34
|
EBITDA
|
-110
|
-109.5
|
-112.8
|
-149.4
|
-51.62
|
-49.29
|
-42.71
|
-
|
-
|
-31.86
|
-
|
-
|
-
|
-
|
EBIT
1 |
-113.6
|
-112.9
|
-116.6
|
-152.8
|
-54.3
|
-52.47
|
-45.01
|
-50.6
|
-44.86
|
-33.51
|
-38.93
|
-38.85
|
-39.07
|
-40.81
|
Operating Margin
|
-455.82%
|
-451.48%
|
-469.58%
|
-708.07%
|
-229.85%
|
-238.25%
|
-208.44%
|
-246.84%
|
-185.82%
|
-140.3%
|
-253.73%
|
-253.25%
|
-254.68%
|
-266.03%
|
Earnings before Tax (EBT)
1 |
-129.6
|
-145.6
|
-90.27
|
-159
|
-59.2
|
-56.54
|
-137.1
|
-51.17
|
-45.9
|
-42.11
|
-40.1
|
-41.85
|
-43.6
|
-44.9
|
Net income
1 |
-129.7
|
-145.6
|
-90.39
|
-159.1
|
-59.05
|
-59.69
|
-137
|
-51.12
|
-45.84
|
-42.08
|
-40.1
|
-41.85
|
-43.6
|
-44.9
|
Net margin
|
-520.47%
|
-582.37%
|
-364.16%
|
-736.94%
|
-249.94%
|
-271.03%
|
-634.52%
|
-249.39%
|
-189.85%
|
-176.17%
|
-261.38%
|
-272.79%
|
-284.19%
|
-292.67%
|
EPS
2 |
-0.7000
|
-0.7900
|
-0.4900
|
-0.8500
|
-0.3100
|
-0.3200
|
-0.7300
|
-0.2700
|
-0.2400
|
-0.2200
|
-0.1967
|
-0.1967
|
-0.1967
|
-0.2033
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-04
|
22-02-28
|
22-05-05
|
22-08-04
|
22-11-03
|
23-02-28
|
23-05-09
|
23-08-08
|
23-11-07
|
24-03-04
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
153
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,062
|
734
|
505
|
35.3
|
115
|
281
|
-
|
Leverage (Debt/EBITDA)
|
-0.359
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-355
|
-321
|
-428
|
-310
|
-193
|
-147
|
-183
|
-176
|
ROE (net income / shareholders' equity)
|
-28.2%
|
-35.8%
|
-59.6%
|
-70.4%
|
-111%
|
-159%
|
-165%
|
-
|
ROA (Net income/ Total Assets)
|
-21.4%
|
-25.3%
|
-39.4%
|
-40.3%
|
-49.8%
|
-36.8%
|
-39.4%
|
-
|
Assets
1 |
2,064
|
1,758
|
1,328
|
913.9
|
554.3
|
456.8
|
425.4
|
-
|
Book Value Per Share
2 |
7.960
|
5.980
|
3.660
|
1.940
|
0.6800
|
0.1700
|
0.4900
|
-
|
Cash Flow per Share
|
-
|
-
|
-2.250
|
-1.620
|
-
|
-
|
-
|
-
|
Capex
1 |
26.3
|
7.26
|
15
|
5.68
|
0.86
|
13
|
-
|
-
|
Capex / Sales
|
22.93%
|
4.75%
|
14.71%
|
6.17%
|
0.95%
|
17.92%
|
-
|
-
|
Announcement Date
|
20-02-27
|
21-02-25
|
22-02-28
|
23-02-28
|
24-03-04
|
-
|
-
|
-
|
Last Close Price
1.57
USD Average target price
1
USD Spread / Average Target -36.31% Consensus |
1st Jan change
|
Capi.
|
---|
| +177.88% | 288M | | +26.08% | 662B | | +21.85% | 546B | | -4.77% | 359B | | +16.97% | 323B | | +5.69% | 290B | | +13.68% | 234B | | +3.65% | 198B | | -11.12% | 194B | | -3.40% | 157B |
Other Pharmaceuticals
|